Ocugen, Inc.Ocugen, Inc.Ocugen, Inc.

Ocugen, Inc.

No trades
See on Supercharts
Market capitalization
‪339.67 M‬USD
−0.27USD
‪−63.08 M‬USD
‪6.04 M‬USD
‪251.67 M‬
Beta (1Y)
1.06

About Ocugen, Inc.

CEO
Shankar Musunuri
Headquarters
Malvern
Website
Employees (FY)
65
Founded
2013
ISIN
US67577C1053
FIGI
BBG00194VJB1
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OCGN is 1.32 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ocugen, Inc. stocks are traded under the ticker OCGN.
Ocugen, Inc. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
OCGN stock is 7.87% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is Ocugen, Inc. there?
One year price forecast for Ocugen, Inc. has a max estimate of 8.00 USD and a min estimate of 7.00 USD.
OCGN earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.07 USD resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about Ocugen, Inc. earnings.
Ocugen, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪2.17 M‬ USD.
Yes, you can track Ocugen, Inc. financials in yearly and quarterly reports right on TradingView.
OCGN stock has fallen by 21.89% compared to the previous week, the month change is a 18.92% rise, over the last year Ocugen, Inc. has showed a 53.72% increase.
OCGN net income for the last quarter is ‪−10.97 M‬ USD, while the quarter before that showed ‪−14.16 M‬ USD of net income which accounts for 22.54% change. Track more Ocugen, Inc. financial stats to get the full picture.
Today Ocugen, Inc. has the market capitalization of ‪339.67 M‬, it has increased by 36.23% over the last week.
No, OCGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocugen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OCGN reached its all-time high on Dec 3, 2014 with the price of 778.20 USD, and its all-time low was 0.17 USD and was reached on Jun 1, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 65.00 employees. See our rating of the largest employees — is Ocugen, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ocugen, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ocugen, Inc. stock shows the sell signal. See more of Ocugen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ocugen, Inc. future price: according to them, OCGN price has a max estimate of 8.00 USD and a min estimate of 7.00 USD. Read a more detailed Ocugen, Inc. forecast: see what analysts think of Ocugen, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ocugen, Inc. EBITDA is ‪−67.46 M‬ USD, and current EBITDA margin is ‪−1.07 K‬%. See more stats in Ocugen, Inc. financial statements.